Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Leukemia Research|June 26, 2024
Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trialsDong-Yeop Shin, Sahee Park, Eunjung Jang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 30, 2017
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in RemissionKyoo-Hyung Lee, Je-Hwan Lee, Jung-Hee Lee, et al.
American Journal of Hematology|April 28, 2011
Clinical effect of reduced-intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated-donorsKyoo-Hyung Lee, Seong-Jun Choi, Je-Hwan Lee, et al.
Blood Research|July 26, 2022
Early diagnosis of Gaucher disease in Korean patients with unexplained splenomegaly: a multicenter observational studyYoung Rok Do, Yunsuk Choi, Mi Hwa Heo, et al.
British Journal of Haematology|February 4, 2020
Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE)Young Rok Do, Jae-Yong Kwak, Jeong A Kim, et al.
Blood Research|June 30, 2021
Lenalidomide for anemia correction in lower-risk del(5q) myelodysplastic syndrome patients of Asian ethnicityJunshik Hong, Yoo Jin Lee, Sung Hwa Bae, et al.
Annals of Hematology|July 27, 2011
Clinical features and outcomes of Hodgkin's lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL)Young-Woong Won, Jung Hye Kwon, Soon Il Lee, et al.
Clinical Lymphoma & Myeloma|September 4, 2008
Bortezomib and the increased incidence of herpes zoster in patients with multiple myelomaSeok Jin Kim, Kihyun Kim, Byung Soo Kim, et al.
International Journal of Hematology|February 12, 2013
Inclusion of hemoglobin level in prognostic score provides better prognostic stratification in patients with acute promyelocytic leukemia (APL)Silvia Park, Su Jin Lee, Kihyun Kim, et al.
Haematologica|July 29, 2010
Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II studySeok Jin Kim, Jong Wook Lee, Chul Won Jung, et al.
Pageof 12